Jose Laborde, PhD

Senior Biostatistician
Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa FL, United States

Presentation(s):

• 64: Hepatic and Overall Progression-Free Survival after Percutaneous Hepatic Perfusion as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma

  Thursday, March 21, 2024
  2:37pm – 2:47pm ET